NovaBay Pharmaceuticals Q3 EPS $(0.02) Beats $(0.08) Estimate, Sales $1.615M Miss $2.05M Estimate

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.08) by 75 percent. This is a 81.82 percent increase over losses of $(0.11) per share from

Benzinga · 11/07/2019 21:07

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.08) by 75 percent. This is a 81.82 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $1.615 million which missed the analyst consensus estimate of $2.05 million by 21.22 percent. This is a 48.60 percent decrease over sales of $3.142 million the same period last year.